hemophagocyt
lymphohistiocytosi
frequent
fatal
clinicopatholog
syndrom
uncontrol
ineffect
immun
respons
lead
sever
hyperinflamm
may
occur
either
famili
disord
sporad
condit
associ
varieti
trigger
infect
malign
autoimmun
diseas
acquir
immun
defici
howev
consist
associ
viral
infect
especi
epstein
barr
viru
main
clinic
featur
fever
liver
dysfunct
coagul
abnorm
pancytopenia
earli
diagnosi
treatment
import
reduc
mortal
diagnosi
difficult
rariti
syndrom
lack
specif
clinic
find
treatment
direct
toward
treat
underli
diseas
suppress
exagger
inflammatori
respons
use
immunosuppress
agent
resumen
la
linfohistiocitosi
es
un
de
potencialment
fatal
en
el
que
una
respuesta
inmun
controlada
e
ineficaz
conduc
pued
aparec
como
una
enfermedad
familiar
asociado
diferent
factor
desencadenant
infeccion
neoplasia
enfermedad
autoinmun
inmunodeficiencia
adquirida
pero
la
consistent
es
con
infeccion
viral
pleas
cite
articl
jl
guerra
laso
j
carriedo
ule
ruiz
de
moral
jmg
linfohistiocitosi
asociada
infeccion
viral
reto
dilema
rev
clin
esp
especialment
el
viru
de
epstein
barr
la
principal
son
fiebr
pancitopenia
el
es
debido
la
rareza
de
est
la
falta
de
especificidad
de
lo
hallazgo
sin
embargo
un
tratamiento
precoc
son
important
para
disminuir
la
mortalidad
el
tratamiento
debe
ser
dirigido
al
control
de
la
enfermedad
subyacent
suprimir
la
respuesta
inflamatoria
exagerada
mediant
el
uso
de
inmunosupresor
elsevi
sl
todo
lo
derecho
reservado
previous
healthi
yearold
male
toxic
habit
admit
sore
throat
fever
cervic
adenopathi
approxim
day
evolut
paulbunnel
test
epstein
barr
viru
ebv
immunoglobulin
test
posit
result
serolog
human
immunodefici
viru
hiv
hepat
viru
neg
stay
ward
mononucleosi
symptom
present
patient
admiss
progress
worsen
includ
hepatosplenomegali
progress
pancytopenia
progress
increas
transaminas
bilirubin
level
blood
cultur
taken
infecti
foci
rule
treatment
start
glucocorticoid
broadspectrum
antibiot
despit
patient
maintain
continu
high
fever
seventh
day
hospit
experienc
renal
respiratori
failur
delirium
blood
urin
cultur
neg
cerebrospin
fluid
normal
patient
evalu
treat
patient
except
diseas
fulmin
hemophagocyt
lymphohistiocytosi
hlh
trig
common
diseas
infecti
mononucleosi
hlh
difficult
diagnos
diseas
due
low
incid
nonspecif
clinic
manifest
progress
sever
system
inflammatori
syndrom
larg
clinic
overlap
sepsi
howev
prognosi
treatment
diseas
differ
hlh
poorer
prognosi
requir
treatment
chemotherapi
case
bone
marrow
transplant
sever
sepsi
better
prognosi
treat
antimicrobi
earli
diagnosi
treatment
hlh
dramat
improv
prognosi
howev
decis
administ
immunosuppress
patient
infecti
diseas
one
present
requir
clinic
expertis
prudenc
hemophagocyt
lymphohistiocytosi
clinicalpatholog
syndrom
uncontrol
ineffect
immun
respons
lead
hyperinflamm
condit
first
describ
scott
robbsmith
report
case
diseas
manifest
fever
adenopathi
organomegali
pancytopenia
histiocyt
infiltr
bone
marrow
invari
fatal
outcom
condit
call
histiocyt
medullari
reticulosi
last
decad
interest
diseas
intensifi
enorm
due
avail
tool
enabl
signific
progress
understand
molecular
mechan
hlh
annual
number
citat
pubm
regard
hlh
multipli
factor
histor
phenotyp
hlh
distinguish
primari
secondari
tabl
primari
hlh
also
call
genet
famili
phenotyp
high
mortal
rate
occur
mainli
infant
genet
abnorm
interfer
function
cytotox
lymphocyt
natur
killer
nk
lymphocyt
transmit
autosom
recess
inherit
two
subgroup
describ
famili
hlh
fhlh
genet
form
associ
primari
immunodefici
includ
disord
link
pigmentari
dilut
pseudoalbin
chediakhigashi
syndrom
griscelli
syndrom
hermanskypudlak
syndrom
lymphoprolif
diseas
associ
chromosom
x
secondari
acquir
hlh
defin
case
hlh
characterist
mutat
diseas
detect
one
sever
trigger
identifi
tabl
infect
hlhi
autoimmun
autoinflammatori
diseas
case
call
macrophageactiv
syndrom
ma
tumor
hlht
especi
tcell
lymphoma
gener
phenotyp
lower
mortal
primari
forma
manifest
frequent
older
children
adolesc
adult
nevertheless
primari
form
also
often
precipit
infect
trigger
hypomorph
heterozyg
mutat
caus
defect
cytotox
report
secondari
form
distinct
primari
secondari
hlh
therefor
becom
increasingli
blur
artifici
incid
hlh
difficult
estim
condit
probabl
underdiagnos
primarili
pediatr
diseas
increas
incid
children
younger
month
nation
retrospect
studi
japan
reveal
hlh
incid
inhabitantsyear
case
children
younger
year
frequenc
variou
form
hlh
vari
accord
age
patient
year
age
hlh
associ
infect
hlhi
common
case
half
associ
ebv
infect
age
group
second
lead
caus
hlh
associ
autoimmun
diseas
ma
follow
hlh
associ
tumor
hlht
patient
group
age
year
hlht
occur
somewhat
less
frequent
hlhi
respect
follow
ma
hlh
associ
bone
marrow
transplant
patient
group
older
year
neoplasm
common
caus
follow
infect
one
quarter
ebv
ma
anoth
recent
retrospect
swedish
studi
show
annual
incid
hlht
adult
individualsyear
fhlh
occur
birth
case
manifest
first
year
life
pathophysiolog
healthi
individu
recognit
foreign
antigen
start
inflammatori
cascad
releas
cytokin
immun
respons
cell
other
induc
prolifer
nk
tlymphocyt
cell
cell
harbor
granul
contain
cytolyt
enzym
perforin
granzym
combin
action
cytolyt
protein
induc
apoptosi
target
cell
elimin
antigen
stimul
signal
termin
inflammatori
respons
fig
variou
mutat
describ
genet
hlh
loci
regul
express
activ
cytotox
granul
effector
cell
lymphocyt
nk
contain
perforin
granzym
explain
deterior
lack
function
respons
mutat
includ
lar
xiap
affect
traffick
intracellular
vesicl
lead
insuffici
level
perforin
defect
vesicular
exocytosi
perforinmedi
cytotox
reduc
absent
elimin
foreign
andor
danger
noxa
host
compromis
antigen
stimul
maintain
termin
switchingoff
immun
respons
defect
lead
hyperactiv
expans
effector
cell
histiocyt
macrophag
cell
infiltr
variou
organ
cytokin
overexpress
cytokin
storm
result
process
uncontrol
ineffect
activ
immun
respons
cellular
damag
multipl
organ
dysfunct
fig
hemophagocytosi
histolog
signatur
diseas
caus
activ
welldifferenti
macrophag
devour
blood
cell
bone
marrow
lymph
node
spleen
liver
organ
howev
hemophagocytosi
might
observ
first
clinic
manifest
hlh
appear
specif
trait
given
also
found
variou
inflammatori
infecti
diseas
acquir
hlh
mechan
lead
defect
cytotox
poorli
control
immun
respons
probabl
multifactori
complet
defin
mechan
includ
hypomorph
mutat
polymorph
gene
regul
immun
respons
interfer
viru
cytotox
function
imbal
infect
effector
cell
line
separ
genet
form
acquir
form
increasingli
blur
clinic
spectrum
hlh
repres
continu
risk
patient
maintain
complet
preserv
immun
function
low
probabl
present
diseas
mutat
affect
cytotox
function
lower
threshold
hlh
appear
larger
contribut
hyperact
mediat
cytotox
therefor
acquir
form
manifest
adult
lie
gray
area
patient
normal
immun
famili
form
sever
defect
cell
immun
manifest
diseas
first
month
life
cardin
clinic
manifest
usual
dramat
affect
organ
includ
high
continu
fever
hepatosplenomegali
cytopenia
symptom
appear
less
frequent
includ
exanthema
jaundic
lymphadenopathi
lethargi
seizur
lung
heart
kidney
disord
common
laboratori
find
reduc
fibrinogen
level
coagulopathi
increas
level
lactat
dehydrogenas
bilirubin
transaminas
triglycerid
ferritin
characterist
immunolog
test
result
increas
plasma
concentr
solubl
receptor
reflect
overal
hyperactiv
immun
respons
nk
cell
defici
characterist
trait
hemophagocytosi
although
clinic
manifest
laboratori
result
characterist
hlh
pathognomon
disord
therefor
histiocyt
societi
propos
join
seri
clinic
criteria
diagnosi
tabl
diseas
difficult
diagnos
probabl
underdiagnos
due
low
incid
variabl
present
nonspecif
clinic
manifest
demonstr
comprehens
review
conduct
sweden
patient
diagnos
death
key
point
confirm
diagnosi
review
medic
histori
perform
complet
medic
examin
laboratori
test
investig
affect
organ
perform
bone
marrow
aspir
biopsi
monitor
ferritin
level
conduct
proper
immunolog
studi
investig
exist
characterist
mutat
famili
form
rule
presenc
trigger
suspect
diseas
face
patient
high
fever
multipleorgan
dysfunct
especi
respond
administr
broadspectrum
antibiot
hemophagocytosi
observ
first
bone
marrow
biopsi
advis
repeat
biopsi
given
might
present
start
symptom
high
ferritin
level
rapidli
increas
highli
suggest
hlh
ferritin
level
gl
sensit
specif
hlh
almost
without
overlap
sepsi
infect
hepat
failur
patient
even
adult
rule
famili
form
without
analyz
genet
mutat
defin
tabl
import
identifi
presenc
potenti
trigger
tabl
given
earli
treatment
condit
sometim
elimin
stimul
immun
activ
clinic
improv
hlh
therebi
avoid
toxic
immunosuppress
tabl
rule
presenc
viral
infect
viral
load
determin
molecular
techniqu
assist
serolog
studi
differenti
diagnos
perform
entiti
produc
high
fever
cytopenia
hepat
dysfunct
visceromegali
without
organ
failur
main
diagnost
challeng
differenti
hlh
diseas
caus
system
inflammatori
respons
syndrom
multipl
organ
dysfunct
especi
sever
sepsi
children
hlh
differenti
storag
diseas
progress
organomegali
kawasaki
diseas
langerhan
cell
histiocytosi
adult
hlh
also
confus
lymphoprolif
syndrom
form
hlh
includ
treat
adequ
high
mortal
prognosi
famili
form
without
treatment
poor
median
surviv
month
mortal
exce
mortal
rate
lower
ma
greater
hlht
especi
associ
tcell
lymphoma
treatment
hlh
consid
follow
compon
support
treatment
complic
organ
failur
aris
clinic
cours
elimin
present
trigger
especi
infect
suppress
exagger
inflammatori
respons
stabl
patient
support
treatment
treatment
underli
diseas
infect
tumor
autoimmun
diseas
start
infecti
diseas
suspect
appropri
diagnost
test
indic
appropri
empir
antimicrobi
treatment
start
diseas
progress
despit
measur
antiinflammatori
andor
immunosuppress
treatment
establish
optim
treatment
hlh
still
known
random
studi
analyz
treatment
therapeut
decis
therefor
base
clinic
experi
expert
recommend
histiocyt
societi
recommend
treatment
hlh
children
includ
follow
dexamethason
cyclosporin
etoposid
known
protocol
intrathec
methotrex
event
neurolog
involv
bone
marrow
transplant
famili
form
refractori
treatment
fhlh
treatment
improv
surviv
cure
diseas
use
protocol
adult
less
studi
case
seri
analysi
indic
use
especi
diseas
associ
viral
infect
tumor
protocol
combin
rituximab
use
success
viral
infect
especi
ebv
infect
treatment
employ
hlh
includ
intraven
administr
immunoglobulin
adult
rheumat
infect
diseas
plasmapheresi
antitnf
drug
associ
autoimmun
diseas
hlh
therapi
complex
due
dynam
cours
diseas
toxic
drug
employ
risk
relaps
therefor
number
expert
design
therapi
algorithm
comprehens
descript
hlh
treatment
beyond
scope
review
found
recent
public
associ
hlh
variou
infect
wide
document
famili
sporad
case
often
precipit
infect
usual
viral
therefor
identif
infect
discrimin
genet
acquir
form
diseas
although
virus
agent
often
associ
hlh
wide
rang
pathogen
also
implic
includ
fungi
bacteria
mycobacteria
parasit
tabl
viral
infectionassoci
hlh
first
describ
risdal
seri
patient
herp
viru
patient
receiv
support
treatment
favor
outcom
persist
infecti
agent
reticuloendotheli
system
relev
factor
indic
report
case
infect
leishmania
mycobacterium
tuberculosi
salmonella
typhimurium
epstein
barr
viru
best
known
precipit
agent
hlh
associ
increasingli
frequent
diseas
famili
sporad
form
ebv
trigger
hlh
children
adult
infecti
agent
identifi
epidemiolog
ebvassoci
hlh
well
known
although
greater
incid
observ
asian
countri
suggest
environment
genet
factor
patient
ebvassoci
hlh
atyp
infecti
mononucleosi
prolong
cours
although
patient
develop
abrupt
rapidli
fatal
diseas
infect
associ
hlh
ebv
infect
poorest
prognosi
especi
presenc
underli
hereditari
disord
determin
viral
load
ebv
import
assess
treatment
respons
prognosi
hyperbilirubinemia
ferritin
level
greater
ngml
diagnosi
factor
poor
prognosi
treatment
strategi
vari
accord
clinic
characterist
infect
mild
case
ebvassoci
hlh
treat
conserv
report
number
patient
spontan
regress
antivir
treatment
acyclovir
ganciclovir
cidofovir
yield
disappoint
result
ebvassoci
hlh
sever
evolut
introduct
immunochemotherapi
dramat
chang
histori
prognosi
diseas
combin
use
protocol
hematopoiet
stemcel
transplant
refractori
case
recurr
surviv
rate
ebvassoci
hlh
drastic
improv
intern
registri
addit
rituximab
antihlh
treatment
steroid
etoposid
andor
cyclosporin
well
toler
improv
clinic
situat
patient
cytomegaloviru
cmv
herp
virus
virus
commonli
associ
hlh
ebv
cytomegaloviru
cmv
human
herp
viru
cmv
activ
express
tumor
necrosi
factor
gene
associ
hlh
healthi
patient
inflammatori
bowel
diseas
rheumat
diseas
cancer
transplant
high
mortal
rate
seri
patient
underw
hematopoiet
stemcel
transplant
patient
develop
hlh
cmv
trigger
case
younger
age
associ
poorer
prognosi
specif
anticmv
treatment
anticmv
immunoglobulin
foscarnet
ganciclovir
effect
report
hlh
associ
infect
children
adult
major
case
occur
patient
kaposi
multicentr
castleman
diseas
especi
patient
hiv
infect
rare
immunocompet
patient
condit
high
mortal
rate
better
treatment
result
report
foscarnet
etoposid
rituximab
herp
simplex
viral
infect
respons
neonat
hlh
case
japan
everi
patient
neonat
hlh
high
mortal
rate
patient
isol
case
describ
adult
human
immunodefici
viru
hiv
hlh
associ
hiv
infect
like
associ
underestim
given
clinic
laboratori
result
similar
hiv
infect
hlh
approxim
bone
marrow
biopsi
hivposit
patient
show
sign
hemophagocytosi
start
antiretrovir
treatment
opportunist
infect
neoplasm
observ
case
acut
chronic
hiv
infect
associ
immun
reconstitut
inflammatori
syndrom
associ
start
antiretrovir
treatment
hlh
also
initi
present
hiv
infect
common
viral
trigger
hlh
patient
hiv
ebv
cmv
recent
seri
patient
present
hlht
especi
lymphoma
associ
underli
infect
especi
herp
viru
tuberculosi
infect
seri
mortal
rate
approxim
similar
hlhi
hlht
whether
patient
underw
specif
treatment
hlh
number
author
relat
cmv
infect
hlh
associ
hiv
infect
recommend
start
anticmv
treatment
ganciclovir
foscarnet
case
virus
hlh
also
associ
less
frequent
virus
includ
influenza
viru
parvoviru
hepatotrop
virus
enterovirus
paramyxoviru
measl
mump
rubella
viru
adenoviru
human
parainfluenza
viru
flaviviru
dengu
hantaviru
hemorrhag
fever
sever
acut
respiratori
syndrom
patient
underw
bone
marrow
biopsi
hemophagocytosi
observ
immunolog
studi
show
decreas
nk
activ
high
level
solubl
receptor
therebi
meet
histiocyt
societi
criteria
tabl
genet
examin
reveal
mutat
characterist
fhlh
patient
diagnos
ebvassoci
hlh
due
sever
symptom
treatment
start
protocol
howev
patient
continu
torpid
cours
ultim
fatal
outcom
numer
neoplast
autoimmun
genet
diseas
trigger
hlh
infecti
agent
especi
virus
often
associ
syndrom
microbi
etiolog
therefor
rule
patient
hlh
combin
high
fever
respond
broad
spectrum
antibiot
organomegali
cytopenia
hyperferritinemia
hypertriglyceridemia
hypofibrinogenemia
along
characterist
histolog
find
bone
marrow
affect
organ
context
infecti
diseas
especi
ebv
infect
also
microorgan
constitut
main
diagnost
clue
antimicrobi
treatment
use
case
although
antivir
agent
seem
benefici
critic
ill
patient
might
requir
immunosuppress
therapi
bone
marrow
transplant
definit
treatment
famili
form
last
resort
refractori
case
associ
viral
infect
manifest
hlh
affect
multipl
system
organ
multidisciplinari
approach
among
clinician
experienc
treatment
diseas
potenti
trigger
therefor
essenti
internist
especi
understand
manifest
hlh
frequent
associ
variou
microorgan
given
earli
diagnosi
treatment
dramat
improv
prognosi
diseas
